Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Conquest Mining Releases ‘Spectacular’ Drilling Results

Jan 29 2007

Market rumours have been vindicated with Conquest Mining reporting ‘spectacular drilling results’, with more to come.


Time To Give Up On Telfer?

Jan 29 2007

Have analysts had enough? It must be time to stop believing Newcrest’s Telfer is ever going to live up to its supposed potential.


Don’t be Misled By Lihir’s Reserves

Jan 25 2007

A 23% increase in gold reserves is not as exciting as it sounds.


Has Oz Inflation Been Beaten?

Jan 25 2007

Yesterday’s CPI data resulted in reduced expectations of a February rate rise, but there are still arguments inflationary pressures remain in the Australian economy.


Gloves Off Again Between Telstra And The ACCC

Jan 25 2007

T3 provided a “truce”, but now that’s put to bed Telstra is back in fighting mode, taking the ACCC to court on a constitutional challenge.


RBA On Hold For Now, Say Economists

Jan 24 2007

The fall in the December quarter CPI has led economists to suggest the RBA will not raise rates next month, but will rather take to the sidelines with a watchful eye.


HPAL Earnings Beat Estimates But Neutral Ratings Maintained

Jan 24 2007

Improved performance in its key essential mail division allowed HPAL to beat earnings expectations, but upgrades to forecasts have not led to upgraded ratings.


Alcan’s Cost Blow-Out Makes Alumina Look Very Cheap

Jan 24 2007

UBS analysts point out that Alumina Ltd is already trading below its NPV and replacement cost, but cost blow-outs for Alcan imply even greater value.


News To Join Recommended List At Macquarie

Jan 23 2007

News Corp will be added to Macquarie’s recommended list shortly, a source tells us.


Merck Sale Would Lift Competition In Australia’s Generic Drug Market

Jan 23 2007

Austock suggests any sale by Merck of its generic drug maker Alphapharm would lift competition in the Australian market as the new owner would move to stem market share losses.



Analyse The Market From A Different Angle